Business
GlaxoSmithKline hoping to deliver Australia’s next COVID treatment – Sydney Morning Herald
The pharma giant has started the approvals process for a drug similar to what Donald Trump received.
GSK announced last year it plans to close its Melbourne manufacturing site in Boronia at the end of 2022 after 50 years. The companys research on the COVID treatment has all taken place overseas, with Australias low case numbers meaning it is difficult to run trials for treatments here.
Australia is currently focused on the rollout of coronavirus vaccines, but the local biotech sector has long said there needs to be more treatment options for patients who present with the virus – particularly as…
-
Noosa News5 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
General21 hours agoPope Francis, the 266th pope, has died
-
General19 hours agoFounder Schwab quits as World Economic Forum chair
-
General6 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing